BioBehavioral Diagnostics

About:

BioBehavioral Diagnostics manufactures technologies for the diagnosis and management of neurological and psychiatric conditions.

Website: http://biobdx.com

Twitter/X: BioBDx

Top Investors: Sevin Rosen Funds, Tullis Health Investors

Description:

BioBehavioral Diagnostics Company manufactures and markets the Quotientâ„¢ ADHD System, a tool that aids in the objective and accurate assessment of ADHD symptoms. They are dedicated to providing physicians, parents and patients with high-value information to guide personalized strategies and to enhance quality of life for patients with ADHD.

Total Funding Amount:

$32.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Westford, Massachusetts, United States

Founded Date:

2004-01-01

Contact Email:

Quotient-ADHD(AT)BioBDx.com

Founders:

Eric Gordon

Number of Employees:

11-50

Last Funding Date:

2013-02-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai